Health ❯ Medicine

Clinical Trials

Drug Development Phase 3 Trials Drug Approval Cancer Treatment Research Studies Drug Efficacy Preclinical Studies Patient Care Cancer Research Drug Testing

Edoxaban Shows No Net Benefit for Atrial Fibrillation Patients After Intracranial Haemorrhage

Investigators recommend individualized care after ENRICH‑AF, citing excess haemorrhagic stroke plus major bleeding with edoxaban

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

AbCellera’s Menopause Antibody Hits Phase 2 Goals

Germline Genetic Variants Shape Safety and Activity of CAR‑T Therapy

NTX-301 Reprograms Epigenetics to Fight Treatment-Resistant AML

Daraxonrasib Doubles Survival in Phase 3 Trial of Treated Metastatic Pancreatic Cancer

Study Links Two Weather Patterns to Higher Headache Risk

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Tumor Inflammation Drives Early Resistance to KRAS Drugs, Study Shows

Asthma Drug Montelukast Restores Checkpoint Response in Preclinical Cancer Models

Real-World Study Finds Tezepelumab Cuts Severe Asthma Flares by 70% Across Diverse Patients

Single CAR T Infusion Clears Residual Disease in High-Risk Smoldering Myeloma Trial

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1

TIE2 Identified as Drug Target in Brain Cavernous Malformations After Mouse Study Stops New Lesions

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

Brazil Moves to Bolster IP After Polylaminin Patent Lapse as First Safety Trial Nears

GSK to Acquire 35Pharma for $950 Million to Add Pulmonary Hypertension Candidate HS235

Oncolytic Viruses Trigger T‑Cell Infiltration and Survival Signals in Early Glioblastoma Trials